OTC - ACTIVE INGREDIENT SECTION
Ingredients: ACTIVE:
Argentum Mettalicum 10x, 20x and 30x HPUS
Ingredients: ACTIVE:
Argentum Mettalicum 10x, 20x and 30x HPUS
Inactive: Silver Hydrosol, carbopol
and Sodium hydroxide
First Aid Gel
Homeopathic Medicine
Keep out of reach of children
Warnings. For external use only.
Ask a doctor before use of you have deep or puncture wounds,
animal bites or serious burns.
Adult supervision required.
Directions. Clean affected area. Apply a liberal,
consistent layer of First Aid Gel. Leave wet or bandage for optimal results. Repeat 3 times
per day or as often as needed to relieve symptoms
Indications for Use: For relief of these symptoms
due to minor wounds and burns, bruises, ulcerations,
sunburn, razor burn, scrapes, rashes, blisters, bug bites,
and skin eruptions form acne, eczema, or minor infection:
burning
stinging
itching
redness
stiffness
minor pain
minor inflammation
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52166-001-01 | Argentyn 23 | 59 mL in 1 BOTTLE | GEL | 59 | 31 | |
| 52166-001-01 | Argentyn 23 | 1 in 1 BOX | GEL | 1 | 31 | |
| 52166-001-02 | Argentyn 23 | 29 mL in 1 BOTTLE | GEL | 29 | 31 | |
| 52166-001-02 | Argentyn 23 | 1 in 1 BOX | GEL | 1 | 31 | |
| 52166-001-03 | Argentyn 23 | 5 mL in 1 POUCH | GEL | 5 | 31 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Silver | ACTIVE INGREDIENT | 3M4G523W1G | 6 | |
| Silver | ACTIVE MOIETY | 3M4G523W1G | 6 | |
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | INACTIVE INGREDIENT | HHT01ZNK31 | 6 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52166-001 | 52166-001-01, 52166-001-02, 52166-001-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| SILVER | 3M4G523W1G | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 29 | 2025-05-22 | full-release | 2026-06-01 02:33:41 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TOPICAL | 81 mg | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TOPICAL | 81 mg | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TOPICAL | 81 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| Sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TOPICAL | 81 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Argentyn 23 | ARGENTUM METALLICAUM | Natural Immunogenics Corp.dba SOVEREIGN NATURALS | cddbd11b-b313-4df8-bd2d-89d4034ce7ad | 2025-10-15 | Warnings | 52166-001-02 52166-001-03 52166-001-01 52166-001 52166000102 52166000101 52166000103 4138481b-ae66-74a0-e063-6394a90a8aff cddbd11b-b313-4df8-bd2d-89d4034ce7ad |
Adverse event summaries are temporarily unavailable. Other product information remains available.